“Healthcare Anywhere” Rewrites Pharma Marketing Rules
By Marc Dresner
Innovators take note: Measurably improved health outcomes may soon fall within the responsibilities of pharmaceutical marketers.
It’s a field afar from conventional DTC, but according to Joe Shields, healthcare delivery is no longer the exclusive domain of hospitals and physicians’ offices; it’s mobile.
As such, there's an opportunity for marketers to have unprecedented influence on treatment outcomes and people's health, in general, as part of their communications strategy.
Commonly known as “mHealth”, Shields and others are now calling the trend “healthcare anywhere”—essentially the ‘consumerization’ of medical treatment via devices (ex. smartphone apps that function as hybrid promotional/behavior modification tools with remote monitoring and diagnostic capabilities, etc.).
In this interview with FEI's Forward Focus, Shields, who was most recently with LifeScan's Global Strategic Marketing group and is now an "at-large" leader in healthcare innovation circles, discusses the extraordinary shift taking place as marketers find themselves poised to play an unprecedented, hands-on role in healthcare.
Download the transcript!
Marc Dresner is IIR USA's senior editor and special communication projects lead. He is the former executive editor of Pharma Market Research Report, a confidential newsletter for marketing researchers in the pharmaceutical industry. He may be reached at email@example.com. Follow him @mdrezz.